Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics

Beckman Coulter introduces two automated systems in UK for microbiology diagnostics

MDBR Staff Writer Published 01 December 2016

Biomedical laboratory instruments maker Beckman Coulter has introduced two automated systems in the UK for microbiology diagnostics to help manage increasing pressure on the NHS.

The DxN VERIS Molecular Diagnostics system is indicated for same-day molecular viral load testing, while the MicroScan Microbiology Systems is for microorganism identification (ID) and antimicrobial susceptibility testing (AST).

According to the company, the high-throughput testing significantly streamlines laboratory workflows and reduces time to patient therapy diagnoses.

Sheffield Teaching Hospital NHS Trust virology laboratory manager Duncan Whittaker said: “The DxN VERIS is the kind of instrumentation that will help the laboratory to meet long terms goals for improved services with faster turnaround times and greater productivity.

“The easy-to-use DxN VERIS system saves both hands-on time and space in the laboratory. Results are available rapidly - facilitating fast decision making and positively impacting patient treatment.”

The company’s MicroScan WalkAway 96 Plus system will enable simultaneous processing of conventional, rapid, and specialty panels.

MicroScan’s true Minimum Inhibitory Concentration (MIC) technology with visual read capability allows to detect emerging resistance in real-time without depending on historical data.

Beckman Coulter is engaged in the development of clinical diagnostic products, including instruments, systems and tests.

The firm provides clinical laboratories with a range of chemistry, immunoassay, haematology, urinalysis, microbiology, automation and information systems.


Image: Beckman Coulter has launched two automated systems in UK. Photo: courtesy of Beckman Coulter.